Neonatal screening for severe combined immunodeficiency syndrome

Detalhes bibliográficos
Autor(a) principal: Bomfim, Vitoria Vilas Boas da Silva
Data de Publicação: 2022
Outros Autores: Araújo, Paulo da Costa, Treptow, Lisiane Madalena, Sousa, Emanuel Osvaldo de, Sousa Júnior, Célio Pereira de, Cabral, Débora Fernandes Barros, Santos, Bruna Raquel Luna Pedroso, Pessoa, Carolina Marques Ribeiro, Silva, Deborah Regina Cavalcante da, Ruela, Guilherme de Andrade
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/33572
Resumo: Severe combined immunodeficiency (SCID), also known as “bubble boy disease” is a serious defect in cellular and humoral immunity that makes children susceptible to infections. Its diagnosis is made through Neonatal Screening, and in Brazil it is done by the foot test. The treatment is based on the Hematopoietic Stem Cell Treatment (HSCT). Late diagnosis or lack of treatment can cause sequelae or death. Therefore, it is important to implement newborn screening to detect cases of SCID early to avoid irreversible damage. Therefore, the objective of this review is to evaluate neonatal screening for severe combined immunodeficiency and its contribution to carriers. This is a systematic literature review approved by the PROSPERO platform under number CDR42020206341, carried out in MEDLINE, LILACS, in English, Portuguese and Spanish, to be reviewed by two independent authors. Randomized and non-randomized clinical trials, case-control trials, cohort studies and cross-sectional studies in the last five years will be included. After the combined search and application of the inclusion and exclusion criteria, 12 articles were selected to compose the final sample. Neonatal screening is performed by different methods around the world, however, regardless of how it is done, it is possible to note its importance within the health of neonates. The ease of collection contributes to quality care, and the information offered during prenatal care ensures that parents are aware of the need to perform the exam to identify early pathologies that can cause sequelae and even deaths.
id UNIFEI_48d0ffd701a5e54e13f33663834e1d6f
oai_identifier_str oai:ojs.pkp.sfu.ca:article/33572
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Neonatal screening for severe combined immunodeficiency syndromeCribado neonatal del síndrome de inmunodeficiencia combinada graveTriagem neonatal para síndrome da imunodeficiência combinada graveSevere Combined ImmunodeficiencyNeonatal ScreeningChild HealthChild health.Immunodeficiencia Combinada GraveTamizaje NeonatalSalud infantil.Imunodeficiência Combinada SeveraTriagem NeonatalSaúde da criança.Severe combined immunodeficiency (SCID), also known as “bubble boy disease” is a serious defect in cellular and humoral immunity that makes children susceptible to infections. Its diagnosis is made through Neonatal Screening, and in Brazil it is done by the foot test. The treatment is based on the Hematopoietic Stem Cell Treatment (HSCT). Late diagnosis or lack of treatment can cause sequelae or death. Therefore, it is important to implement newborn screening to detect cases of SCID early to avoid irreversible damage. Therefore, the objective of this review is to evaluate neonatal screening for severe combined immunodeficiency and its contribution to carriers. This is a systematic literature review approved by the PROSPERO platform under number CDR42020206341, carried out in MEDLINE, LILACS, in English, Portuguese and Spanish, to be reviewed by two independent authors. Randomized and non-randomized clinical trials, case-control trials, cohort studies and cross-sectional studies in the last five years will be included. After the combined search and application of the inclusion and exclusion criteria, 12 articles were selected to compose the final sample. Neonatal screening is performed by different methods around the world, however, regardless of how it is done, it is possible to note its importance within the health of neonates. The ease of collection contributes to quality care, and the information offered during prenatal care ensures that parents are aware of the need to perform the exam to identify early pathologies that can cause sequelae and even deaths.La inmunodeficiencia combinada severa (SCID), también conocida como “enfermedad del niño burbuja”, es un defecto grave en la inmunidad celular y humoral que hace que los niños sean susceptibles a las infecciones. Su diagnóstico se realiza a través del Tamizaje Neonatal, y en Brasil se realiza por la prueba del pie. El tratamiento se basa en el Tratamiento de Células Madre Hematopoyéticas (TPH). El diagnóstico tardío o la falta de tratamiento pueden causar secuelas o la muerte. Por lo tanto, es importante implementar el tamizaje neonatal para detectar casos de SCID de manera temprana para evitar daños irreversibles. Por lo tanto, el objetivo de esta revisión es evaluar el tamizaje neonatal para inmunodeficiencia combinada severa y su contribución a los portadores. Esta es una revisión sistemática de la literatura aprobada por la plataforma PROSPERO con el número CDR42020206341, realizada en MEDLINE, LILACS, en inglés, portugués y español, para ser revisada por dos autores independientes. Se incluirán ensayos clínicos aleatorizados y no aleatorizados, ensayos de casos y controles, estudios de cohortes y estudios transversales en los últimos cinco años. Después de la búsqueda combinada y la aplicación de los criterios de inclusión y exclusión, se seleccionaron 12 artículos para componer la muestra final. El tamizaje neonatal se realiza por diferentes métodos alrededor del mundo, sin embargo, independientemente de cómo se realice, es posible notar su importancia dentro de la salud de los recién nacidos. La facilidad de recolección contribuye a la calidad de la atención, y la información ofrecida durante el prenatal asegura que los padres sean conscientes de la necesidad de realizar el examen para identificar tempranamente patologías que pueden causar secuelas e incluso la muerte.A imunodeficiência combinada grave (SCID), também conhecida como “doença do menino da bolha” é um defeito grave na imunidade celular e humoral que torna as crianças suscetíveis à infecções. Seu diagnóstico se dá através da Triagem Neonatal, e no Brasil é feita pelo teste do pezinho. O tratamento é feito a partir do Tratamento de Células-Tronco Hematopoiéticas (TCTH). O diagnóstico tardio ou a ausência de tratamento podem ocasionar sequelas ou óbitos. Portanto, é importante implementar a triagem neonatal para detectar os casos de SCID precocemente para evitar danos irreversíveis. Por isso, o objetivo desta revisão é avaliar a triagem neonatal para imunodeficiência combinada grave e sua contribuição para os portadores. Trata-se de uma revisão sistemática de literatura aprovada pela plataforma PROSPERO sob nº CDR42020206341, realizada nas bases MEDLINE, LILACS, nos idiomas inglês, português e espanhol, a ser revisados por dois autores independentes. Serão incluídos ensaios clínicos randomizados e não randomizados, ensaios de caso controle, estudos de coorte e estudos transversais, nos últimos cinco anos. Após a busca combinada e aplicação dos críterios de inclusão e exclusão foram selecionados 12 artigos para compor a amostra final. A triagem neonatal é realizada por diferentes métodos ao redor do mundo, no entanto, independente de como seja feita, é possível notar a sua importância dentro da saúde de neonatos. A facilidade na coleta contribui para uma assistência de qualidade, e as informações oferecidas durante o pré-natal garantem que os genitores estejam cientes da necessidade em realizar o exame para identificar de forma precoce patologias que podem ocasionar sequelas e até óbitos.Research, Society and Development2022-08-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3357210.33448/rsd-v11i11.33572Research, Society and Development; Vol. 11 No. 11; e104111133572Research, Society and Development; Vol. 11 Núm. 11; e104111133572Research, Society and Development; v. 11 n. 11; e1041111335722525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/33572/28247Copyright (c) 2022 Vitoria Vilas Boas da Silva Bomfim; Paulo da Costa Araújo; Lisiane Madalena Treptow; Emanuel Osvaldo de Sousa; Célio Pereira de Sousa Júnior; Débora Fernandes Barros Cabral; Bruna Raquel Luna Pedroso Santos; Carolina Marques Ribeiro Pessoa; Deborah Regina Cavalcante da Silva; Guilherme de Andrade Ruelahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBomfim, Vitoria Vilas Boas da Silva Araújo, Paulo da Costa Treptow, Lisiane Madalena Sousa, Emanuel Osvaldo de Sousa Júnior, Célio Pereira de Cabral, Débora Fernandes Barros Santos, Bruna Raquel Luna Pedroso Pessoa, Carolina Marques Ribeiro Silva, Deborah Regina Cavalcante da Ruela, Guilherme de Andrade 2022-09-05T13:24:46Zoai:ojs.pkp.sfu.ca:article/33572Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:49:10.898425Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Neonatal screening for severe combined immunodeficiency syndrome
Cribado neonatal del síndrome de inmunodeficiencia combinada grave
Triagem neonatal para síndrome da imunodeficiência combinada grave
title Neonatal screening for severe combined immunodeficiency syndrome
spellingShingle Neonatal screening for severe combined immunodeficiency syndrome
Bomfim, Vitoria Vilas Boas da Silva
Severe Combined Immunodeficiency
Neonatal Screening
Child Health
Child health.
Immunodeficiencia Combinada Grave
Tamizaje Neonatal
Salud infantil.
Imunodeficiência Combinada Severa
Triagem Neonatal
Saúde da criança.
title_short Neonatal screening for severe combined immunodeficiency syndrome
title_full Neonatal screening for severe combined immunodeficiency syndrome
title_fullStr Neonatal screening for severe combined immunodeficiency syndrome
title_full_unstemmed Neonatal screening for severe combined immunodeficiency syndrome
title_sort Neonatal screening for severe combined immunodeficiency syndrome
author Bomfim, Vitoria Vilas Boas da Silva
author_facet Bomfim, Vitoria Vilas Boas da Silva
Araújo, Paulo da Costa
Treptow, Lisiane Madalena
Sousa, Emanuel Osvaldo de
Sousa Júnior, Célio Pereira de
Cabral, Débora Fernandes Barros
Santos, Bruna Raquel Luna Pedroso
Pessoa, Carolina Marques Ribeiro
Silva, Deborah Regina Cavalcante da
Ruela, Guilherme de Andrade
author_role author
author2 Araújo, Paulo da Costa
Treptow, Lisiane Madalena
Sousa, Emanuel Osvaldo de
Sousa Júnior, Célio Pereira de
Cabral, Débora Fernandes Barros
Santos, Bruna Raquel Luna Pedroso
Pessoa, Carolina Marques Ribeiro
Silva, Deborah Regina Cavalcante da
Ruela, Guilherme de Andrade
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bomfim, Vitoria Vilas Boas da Silva
Araújo, Paulo da Costa
Treptow, Lisiane Madalena
Sousa, Emanuel Osvaldo de
Sousa Júnior, Célio Pereira de
Cabral, Débora Fernandes Barros
Santos, Bruna Raquel Luna Pedroso
Pessoa, Carolina Marques Ribeiro
Silva, Deborah Regina Cavalcante da
Ruela, Guilherme de Andrade
dc.subject.por.fl_str_mv Severe Combined Immunodeficiency
Neonatal Screening
Child Health
Child health.
Immunodeficiencia Combinada Grave
Tamizaje Neonatal
Salud infantil.
Imunodeficiência Combinada Severa
Triagem Neonatal
Saúde da criança.
topic Severe Combined Immunodeficiency
Neonatal Screening
Child Health
Child health.
Immunodeficiencia Combinada Grave
Tamizaje Neonatal
Salud infantil.
Imunodeficiência Combinada Severa
Triagem Neonatal
Saúde da criança.
description Severe combined immunodeficiency (SCID), also known as “bubble boy disease” is a serious defect in cellular and humoral immunity that makes children susceptible to infections. Its diagnosis is made through Neonatal Screening, and in Brazil it is done by the foot test. The treatment is based on the Hematopoietic Stem Cell Treatment (HSCT). Late diagnosis or lack of treatment can cause sequelae or death. Therefore, it is important to implement newborn screening to detect cases of SCID early to avoid irreversible damage. Therefore, the objective of this review is to evaluate neonatal screening for severe combined immunodeficiency and its contribution to carriers. This is a systematic literature review approved by the PROSPERO platform under number CDR42020206341, carried out in MEDLINE, LILACS, in English, Portuguese and Spanish, to be reviewed by two independent authors. Randomized and non-randomized clinical trials, case-control trials, cohort studies and cross-sectional studies in the last five years will be included. After the combined search and application of the inclusion and exclusion criteria, 12 articles were selected to compose the final sample. Neonatal screening is performed by different methods around the world, however, regardless of how it is done, it is possible to note its importance within the health of neonates. The ease of collection contributes to quality care, and the information offered during prenatal care ensures that parents are aware of the need to perform the exam to identify early pathologies that can cause sequelae and even deaths.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-16
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/33572
10.33448/rsd-v11i11.33572
url https://rsdjournal.org/index.php/rsd/article/view/33572
identifier_str_mv 10.33448/rsd-v11i11.33572
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/33572/28247
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 11; e104111133572
Research, Society and Development; Vol. 11 Núm. 11; e104111133572
Research, Society and Development; v. 11 n. 11; e104111133572
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052770663006208